Noninvasive tests for CAD unsuitable in renal failure patients
- Joanna Lyford1
© Biomed Central Ltd 2001
Received: 7 March 2001
Published: 18 October 2001
KeywordsCoronary artery disease, diagnosis, mass screening, sensitivity, specificity
It was thought that many common tests for coronary artery disease (CAD) are considered to be of little use in patients with end-stage renal disease. This paper tested the accuracy of some common tests.
Angina pectoris was the clinical symptom that most accurately predicted the presence of CAD, with a sensitivity of 65% and a specificity of 66%. The corresponding positive and negative likelihood ratios were 1.9 and 0.5. Neither resting ECG, which had a sensitivity of 67% and a specificity of 52%, nor dipyridamole thallium-201 scintigraphy, which had a 1.3 positive likelihood ratio and a 0.5 negative likelihood ratio, were useful in diagnosing CAD. The sensitivity of exercise testing was also low, since most patients were not physically able to complete the test.
Gert Mayer, a co-author, concluded that investigative methods that are of value in the general population do not help a lot in patients with end-stage renal disease. Widespread left ventricular hypertrophy in renal transplant recipients and dialysis patients makes radionucleotide imaging unreliable as well as the methods studied. He suggests that an aggressive approach using angiography needs to be taken to be sure about disease severity.
Various tests for CAD were evaluated, including clinical symptoms, electrocardiography (ECG), angiography, dipyridamole thallium-201 scintigraphy, and exercise testing. In total, 84 patients were studied; 42 were on hemodialysis and 42 were renal transplant patients. Angiography results that 43 (51%) had significant CAD.